Capital Change Notice

Section 1: Issuer information Name of issuer Ryman Healthcare Limited NZX ticker code RYM010 Class of financial product Fixed rate, secured, unsubordinated bonds ("Bonds") ISIN (If unknown, check on NZX website) NZRYMD0010L2 Currency NZD Section 2: Capital change details Number issued/acquired/redeemed 150,000,000 Nominal value (if any) $1.00 Issue/acquisition/redemption price per security $1.00 Nature of the payment (for example, cash or other consideration) Cash Amount paid up (if not in full) Fully paid up Percentage of total class of Financial Products issued/acquired/redeemed/ (calculated on the number of Financial Products of the Class, excluding any Treasury Stock, in existence) 100% For an issue of Convertible Financial Products or Options, the principal terms of Conversion (for example the Conversion price and Conversion date and the ranking of the Financial Product in relation to other Classes of Financial Product) or the Option (for example, the exercise price and exercise date) N/A Reason for issue/acquisition/redemption and specific authority for issue/acquisition/redemption/ (the reason for change must be identified here) The purpose of the offer is to provide diversity of funding sources and tenor, and the proceeds of the offer will be used to repay a portion of Ryman's existing bank debt. This will provide Ryman with additional headroom under Ryman's Bank Facility Agreement which it can drawdown as required. Issue authorised by resolution of the Board at a meeting on 23 November 2020. Total number of Financial Products of the Class after the issue/acquisition/redemption/Conversion (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue/acquisition/redemption. 150,000,000 In the case of an acquisition of shares, whether those shares are to be held as treasury stock N/A Specific authority for the issue, acquisition, or redemption, including a reference to the rule pursuant to which the issue, acquisition, or redemption is made Issue authorised by resolution of the Board at a meeting on 23 November 2020. Rule 3.13.1 Terms or details of the issue, acquisition, or redemption (for example: restrictions, escrow arrangements) As described in the Product Disclosure Statement dated 26 November 2020. Date of issue/acquisition/redemption 18 December 2020 Section 3: Authority for this announcement and contact person Name of person authorised to make this announcement David Bennett, Chief Financial Officer Contact person for this announcement David Bennett Contact phone number 0800 588 222 Contact email address david.bennett@rymanhealthcare.com Date of release through MAP 18 December 2020 End CA:00365292 For:RYM Type:SECISSUE Time:2020-12-18 09:02:58